Latest current assets for RAPT: $160M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
RAPT Therapeutics (RAPT) currently reports a current assets of $160M as of September 2025. That compares with $100M in the prior-year period — up 57.0% year over year. Use the charts on this page to explore RAPT Therapeutics's current assets history and peer comparisons.
RAPT Therapeutics's current assets increased from $100M to $160M — a 57.0% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
RAPT Therapeutics reported $160M in current assets as of September 2025. That compares with $100M in the prior-year period — up 57.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $160M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for RAPT Therapeutics, and consider following RAPT for alerts when major investors trade the stock.
RAPT Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $160M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RAPT with unrelated industries.